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Abstract
Background: The chest pain unit (CPU) has been developed to provide a rapid and accurate
diagnostic assessment for patients attending hospital with acute, undifferentiated chest pain. We
aimed to measure the effect of CPU assessment upon psychological symptoms and health-related
quality of life.
Methods: We undertook a single-centre, cluster-randomised controlled trial. Days (N = 442)
were randomised in equal numbers to CPU or routine care. Patients with acute chest pain,
undiagnosed by clinical assessment, ECG and chest radiograph, were recruited and followed up
with self-completed questionnaires (SF-36 and HADS) at two days and one month after hospital
attendance.
Results:  Patients receiving CPU assessment had significantly higher scores on the physical
functioning (difference 5.1 points; 95% CI 1.1 to 9.0), vitality (4.6; 1.3 to 8.0), and general health
(5.7; 2.3 to 9.2) dimensions of the SF-36 at two days, and significantly higher scores on all except
the emotional role dimension at one month. They also had significantly lower depression scores
on the HADS depression scale at two days (0.93; 0.34 to 1.51) and one month (1.0; 0.36 to 1.66).
However, initially lower anxiety scores at two days (0.89; 0.21 to 1.56) were not maintained at one
month (0.48; -0.26 to 1.23). CPU assessment was associated with reduced prevalence (OR 0.71;
95% CI 0.52 to 0.97) and severity (6.5 mm on 100 m visual analogue scale; 95% CI 2.2 to 10.8) of
chest pain at one month, but no significant difference in the proportion of patients taking time off
work (OR 0.82; 95% CI 0.54 to 1.04).
Conclusion: CPU assessment is associated with improvements in nearly all dimensions of quality
of life and with reduced symptoms of depression.
Background
Acute chest pain is a common reason for emergency hos-
pital attendance and admission. Patients with chest pain
that remains undiagnosed after clinical assessment, ECG
and chest radiograph pose a particular problem. They
carry a low, but important risk of an acute coronary syn-
drome [1]. The potentially life-threatening nature of this
diagnosis means that a cautious approach is often taken,
with many patients being admitted to hospital for obser-
vation and investigation [2]. Yet most patients with
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undifferentiated chest pain do not have a coronary syn-
drome, whereas anxiety and psychological morbidity are
common [3-5] and appear to be associated with impaired
quality of life [6]. It is possible that anxiety could be influ-
enced by the investigation and management of chest pain.
If this is so, then decision analysis modelling suggests that
the potential health gains that could be achieved by reduc-
ing anxiety and improving quality of life among the
majority of patients who do not have an acute coronary
syndrome substantially outweigh the potential health
gains from detecting and treating acute coronary syn-
dromes [7].
The chest pain unit (CPU) was developed to provide rapid
and accurate diagnosis for patients presenting with acute
undifferentiated chest pain [8]. Patients receive up to six
hours of observation and biochemical testing followed by
an exercise treadmill test. If these tests are positive then
they are admitted to hospital with a clear diagnosis, if neg-
ative they are discharged home. Evaluation of CPU care
has focussed upon cardiac events, process measures and
economic measures [9]. There is some evidence that CPU
care is associated with improved diagnostic certainty [10]
and patient satisfaction [11], but no data to compare psy-
chological morbidity and quality of life after CPU and
routine care, despite substantial data to suggest that this is
an important problem for patients [3-5,12-14].
The ESCAPE (effectiveness and safety of chest pain evalu-
ation to prevent emergency admission) trial was a ran-
domised controlled trial and economic evaluation of CPU
versus routine care that showed that CPU care was associ-
ated with reduced hospital admission [15], improved
health utility [15] and improved patient satisfaction [16],
and was likely to be considered cost-effective [15]. This
paper reports quality of life and psychological measures
from the ESCAPE trial. We aimed to measure the effect of
CPU care upon anxiety, depression, and health related
quality of life, and to determine whether CPU care
reduced subsequent symptoms of chest pain.
Methods
The Northern General Hospital Emergency Department
provides adult emergency care to the 530,000 population
of Sheffield, United Kingdom. In 1999 a CPU was estab-
lished in the emergency department, staffed by three spe-
cialist chest pain nurses, and able to accommodate up to
six patients with acute undifferentiated pain. Patients
were selected using validated clinical predictors and
received two to six hours of observation and biochemical
cardiac testing, followed by, where appropriate, an exer-
cise treadmill test. Full details of the CPU protocol have
been published [17]. Routine care, prior to development
of the CPU, consisted of assessment by a doctor who had
access to biochemical cardiac tests, but not observation
facilities or exercise treadmill testing.
From 5th February 2001 to 5th May 2002 the CPU was sub-
ject to a cluster randomised controlled trial. Days of the
week (N = 442) were randomised to CPU or routine care
in equal numbers. All patients attending with acute chest
pain were screened for eligibility in the trial. Patients were
excluded if they had ECG changes diagnostic for an acute
coronary syndrome, clinically obvious unstable angina,
co-morbidity or alternative pathology requiring hospital
admission (e.g. suspected pulmonary embolus), negligi-
ble risk of acute coronary syndrome (e.g. age less than 25
years), or if they were unable to consent to participation.
Written, informed consent was requested and patients
who agreed to participate were followed up in a review
clinic at two days, and by postal questionnaire at one
month. The study protocol was approved by the North
Sheffield Research Ethics Committee. Full details of the
ESCAPE trial have been published [15].
Health related quality of life was measured using the SF-
36 questionnaire [18]. Anxiety and depression were meas-
ured using the Hospital Anxiety Depression Scale (HADS)
[19]. Both are widely used, validated, self-completed
questionnaires. Both were administered at two days and
one month. At two days patients were handed the ques-
tionnaires in the review clinic and asked to complete it in
their own time and return it to the Medical Care Research
Unit. No reminder was sent to non-responders to this
questionnaire. Further questionnaires were mailed at one
month with one re-mailing for non-responders.
A brief additional questionnaire was sent at one month
that was designed specifically for the study. This predom-
inantly asked questions about health service use for the
economic evaluation, but also asked participants whether
they had suffered any further chest pain. If they responded
that they had, they were asked to score the severity of the
chest pain on a 100 mm visual analogue scale. A further
question asked whether the patient had taken time off
work since their hospital attendance.
The sample size estimate of 988 was based upon the pri-
mary outcome measure, the proportion of patients admit-
ted to hospital. Assuming a response rate of 65% to the
questionnaires, this sample size would provide 80%
power to detect an effect size of 0.25 for these outcomes
(alpha = 0.05). Using standard deviations derived from a
two-week pilot study, this effect size equates to 1.1 points
on the HADS anxiety or depression scores, 11.5 points of
the SF-36 physical or emotional role dimensions, and 6
points on the other SF-36 dimensions. Data was analysed
using Stata statistical software (version 8.0). Multi-level
random effects modelling was used with day of week as aHealth and Quality of Life Outcomes 2004, 2:39 http://www.hqlo.com/content/2/1/39
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random effect to adjust for clustering by day of week. For
the principal analysis no adjustment for confounding was
made. For secondary analysis age, gender and past history
of coronary heart disease were included as covariates
(determined a priori to be important potential confound-
ers), along with any variable that showed significant (p <
0.05) baseline imbalance between the study groups.
Results
During the 442-day study period there were 6957 attend-
ances with chest pain or a related complaint. Of these, 764
(11.0%) had ECG changes diagnostic for an acute coro-
nary syndrome, 2402 (34.5%) had clinically obvious
unstable angina, 869 (12.5%) had co-morbidity or alter-
native pathology requiring hospital admission, 1291
(18.6%) had negligible risk of acute coronary syndrome,
and 513 patients (7.4%) were unable to participate in the
trial or provide consent. The remaining 1118 patients
(16.1%) were asked to participate in the trial and 972
agreed (86.9%). Response rates were: 717 (73.8%) to the
initial questionnaire and 679 (69.9%) to the one-month
questionnaire. The CONSORT diagram and full details of
exclusions have been published elsewhere [15]. Baseline
characteristics of the study groups are shown in Table 1.
Source of referral, smoking status, and ECG at presenta-
tion showed significant baseline imbalance. Hence sec-
ondary analyses adjusted for these covariates, along with
age, gender and past history of coronary heart disease.
Table 2 shows the final diagnosis recorded in the case
notes, after hospital attendance and admission, of the
most senior clinician to care for the patient. Those receiv-
ing routine care were more likely to have received a diag-
nosis of angina, whereas those receiving CPU care were
more likely to have received a non-specific or non-cardiac
diagnosis.
Table 3 shows the mean SF-36 scores for both groups at
two days, with the adjusted difference, 95% confidence
interval, p-value and intraclass correlation coefficient.
Table 4 shows these estimates at one month. At two days,
CPU care was associated with significant improvements in
physical functioning, vitality and general health. At one
month, CPU care was associated with significant improve-
ments in all dimensions of quality of life, except the emo-
tional role dimension.
Table 1: Baseline characteristics of the study groups
CPU care Routine care
Age (years) 49.4 49.6
Male sex (%) 304 (63.5%) 318 (64.5%)
Known CHD (%) 16 (3.3%) 27 (5.5%)
Hypertension (%) 127 (26.5%) 120 (24.3%)
Diabetes (%) 17 (3.5%) 29 (5.9%)
Hyperlipidaemia (%) 58 (12.1%) 70 (14.2%)
Smoker (%) 169 (35.3%) 143 (29.0%)
Family history (%) 189 (39.5%) 200 (40.6%)
Pain nature
Indigestion / burning 60 (12.5%) 56 (11.4%)
Stabbing / sharp 116 (24.2%) 113 (22.9%)
Aching / dull / heavy 175 (36.5%) 181 (36.7%)
Gripping / crushing 66 (13.8%) 59 (12.0%)
Other 57 (11.9%) 71 (14.4%)
Pain site
Central 317 (66.2%) 335 (68.0%)
Left chest 129 (26.9%) 125 (25.4%)
Right chest 19 (4.0%) 16 (3.2%)
Other 8 (1.7%) 8 (1.6%)
Pain radiation
None 183 (38.2%) 189 (38.3%)
Left arm 118 (24.6%) 142 (28.8%)
Right arm 31 (6.5%) 26 (5.3%)
Neck 22 (4.6%) 22 (4.5%)
Jaw 15 (3.1%) 13 (2.6%)
Back 70 (14.6%) 53 (10.8%)
Other 27 (5.6%) 30 (6.1%)
Pain duration
Continuous pain 312 (65.1%) 341 (69.2%)
Intermittent pain 93 (19.4%) 95 (19.3%)
Other symptoms
Nausea 129 (26.9%) 161 (32.7%)
Vomiting 25 (5.2%) 31 (6.3%)
Dyspnoea 185 (38.6%) 202 (41.0%)
Sweating 192 (40.1%) 210 (42.6%)
ECG at presentation
ECG normal (%) 412 (89.0%) 382 (82.2%)
ECG non-specific (%) 38 (8.2%) 64 (13.8%)
ECG old change (%) 13 (2.8%) 19 (4.1%)
Source of referral
GP referral 138 (28.8%) 116 (23.5%)
Self referred 173 (36.1%) 155 (31.4%)
999 145 (30.3%) 189 (38.3%)
Other 23 (4.8%) 33 (6.7%)
Table 2: Diagnostic impression after initial hospital attendance
Diagnosis CPU care Routine care
Non-specific chest pain 144 (30.1%) 125 (25.4%)
Anxiety 13 (2.7%) 21 (4.3%)
Angina 63 (13.2%) 123 (24.9%)
Myocardial infarction 28 (5.8%) 27 (5.5%)
Gastro-oesophageal pain 74 (15.4%) 60 (12.2%)
Musculo-skeletal pain 122 (25.5%) 106 (21.5%)
Other diagnosis 26 (5.4%) 18 (3.7%)
Not recorded 9 (1.9%) 13 (2.6%)
P < 0.0001 for the difference in distribution across the categoriesHealth and Quality of Life Outcomes 2004, 2:39 http://www.hqlo.com/content/2/1/39
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Table 5 shows the summary HADS data at two days and
one month. CPU care was associated with lower depres-
sion scores at both two days and one month. An early sig-
nificant reduction in anxiety associated with CPU care was
no longer significant at one month. HADS data is also
summarised in the Figure 1, categorised according to
severity of anxiety and depression. Scores of zero to seven
are normal, eight to ten are mild, eleven to fourteen are
Table 3: Mean SF-36 scores at two days
N (% completed) CPU care Routine care Difference 95% CI P-value ρ
Unadjusted
Adjusted
Physical functioning 694 (96.7%) 74.8 69.7 5.1 1.1 to 9.0 0.012 0.002
4.2 0.4 to 7.9 0.029
Social functioning 703 (98.0%) 72.2 69.8 2.4 -1.7 to 6.6 0.252 0
1.5 -2.7 to 5.6 0.49
Role-physical 684 (95.4%) 50.4 46.0 4.4 -2.2 to 11.0 0.191 0.028
3.3 -3.3 to 10.0 0.326
Role-emotional 685 (95.5%) 64.7 59.5 5.2 -1.2 to 11.6 0.113 0
5.1 -1.2 to 11.4 0.111
Mental health 700 (97.6%) 66.9 64.7 2.2 -0.9 to 5.3 0.158 0
2.3 -0.7 to 5.4 0.132
Vitality 697 (97.2%) 52.3 47.6 4.6 1.3 to 8.0 0.007 0
4.6 1.3 to 8.0 0.007
Pain index 701 (97.7%) 50.8 49.0 1.8 -1.9 to 5.5 0.351 0
2.0 -1.7 to 5.7 0.284
General health 688 (96.0%) 60.3 54.5 5.7 2.3 to 9.2 0.001 0
5.4 2.0 to 8.8 0.002
Upper row shows unadjusted analysis (primary analysis) Lower row shows adjusted analysis (secondary analysis) ρ = Intraclass correlation 
coefficient. This provides a measure of the amount of clustering of each outcome by the unit of randomisation (day).
Table 4: Mean SF-36 scores at one month
N (% completed) CPU care Routine care Difference 95% CI P-value ρ
Unadjusted
Adjusted
Physical functioning 654 (96.3%) 74.1 66.2 7.8 3.8 to 11.9 <0.001 0.025
7.6 3.6 to 11.5 <0.001
Social functioning 654 (96.3%) 74.6 67.0 7.6 3.2 to 12.0 0.001 0
6.8 2.4 to 11.2 0.002
Role-physical 638 (94.0%) 54.1 46.0 8.2 1.3 to 15.0 0.02 0
7.0 0.4 to 13.6 0.039
Role-emotional 630 (92.8%) 63.9 60.2 3.7 -3.0 to 10.5 0.281 0
3.9 -2.8 to 10.5 0.256
Mental health 653 (96.2%) 69.1 64.4 4.7 1.3 to 8.2 0.007 0
5.2 1.9 to 8.6 0.002
Vitality 649 (95.6%) 52.6 47.1 5.5 1.8 to 9.2 0.003 0
5.8 2.2 to 9.3 0.002
Pain index 655 (96.5%) 66.4 62.0 4.4 0.2 to 8.5 0.04 0
4.3 0.2 to 8.3 0.041
General health 651 (95.9%) 59.7 51.7 8.0 4.6 to 11.5 <0.001 0
8.1 4.6 to 11.5 <0.001
Upper row shows unadjusted analysis (primary analysis) Lower row shows adjusted analysis (secondary analysis) ρ = Intraclass correlation 
coefficientHealth and Quality of Life Outcomes 2004, 2:39 http://www.hqlo.com/content/2/1/39
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moderate, and fifteen to twenty-one are severe. Most par-
ticipants had normal levels of depression, but only half
reported normal levels of anxiety. CPU care was associ-
ated with increased prevalence of normal levels of anxiety
at two days (53.4% vs 45.1%; p = 0.028) but not at one
month (56.7% vs 50.8%; p = 0.129), and increased prev-
alence of normal levels of depression at two days (81.8%
vs 72.9%; p = 0.005) and one month (80.4% vs 73.2%; p
= 0.029).
At one-month follow-up, 143 out of 318 participants
(45.0%) receiving CPU care reported having further pain,
compared to 168 out of 314 (53.5%) receiving routine
care (unadjusted OR for further pain if receiving CPU care
= 0.71, 95% CI 0.52 to 0.97, p = 0.032; adjusted OR =
0.65, 95% CI 0.10 to 0.76, p = 0.010). For those reporting
further pain, the mean score on a 100 mm visual analogue
pain score was 36.5 mm among those receiving CPU care
and 43.0 mm among those receiving routine care (unad-
justed difference = 6.5 mm, 95% CI 2.2 to 10.8, p = 0.003;
adjusted difference= 6.8 mm, 95% CI 2.2 to 11.5, p =
0.004). Thus, at one month, CPU care was associated with
a reduction in the incidence and severity of subsequent
chest pain.
One month after hospital attendance, 49 out of 315 par-
ticipants receiving CPU care (15.6%) reported that they
had taken time off work, compared to 58 out of 316
receiving routine care (18.4%). The unadjusted odds ratio
for taking time off work after receiving CPU care was 0.82
(95% CI 0.54 to 1.24, p = 0.35; adjusted OR 0.79 (95% CI
0.59 to 1.22, p = 0.287).
Discussion
Main findings
Patients with acute, undifferentiated chest pain who
received CPU care had improved quality of life and
reduced psychological symptoms. All dimensions of qual-
ity of life were improved at one month apart from the
emotional role dimension. Anxiety was reduced two days
after assessment, but there was no significant difference by
one month, whereas reduced symptoms of depression at
one month were still significant at one month. Patients
receiving CPU care reported that subsequent symptoms of
chest pain were less frequent and (if present) less severe.
However, these reported differences in symptoms and
quality of life were not associated with any significant dif-
ference in the need to take time off work.
Comparison to other studies
Previous studies of CPU care have focussed on cardiac
events, process measures and economic measures [9].
One previous randomised trial found that CPU care was
associated with greater diagnostic certainty [10] and
improved patient satisfaction [11]. Our study suggests a
more complicated picture, since more patients in the CPU
group received a diagnosis of non-specific chest pain. CPU
assessment may allow cardiac disease to be ruled out, but
if an alternative diagnosis is not offered then this can
hardly be said to increase diagnostic certainty, except in
the somewhat convoluted sense that we may be more cer-
tain of what we know the cause is not.
Nevertheless, CPU assessment was associated with
reduced anxiety and improved quality of life. This is con-
sistent with a previous study of diagnostic testing by Sox
et al [20] that showed reduced anxiety among patients
who were randomised to a more thorough outpatient
diagnostic work-up for non-specific chest pain, but incon-
Table 5: Mean HADS scores at two days and one month
N (% completed) CPU care Routine care Difference 95% CI P-value ρ
Unadjusted
Adjusted
Anxiety- two days 702 (97.9%) 7.73 8.62 0.89 0.21 to 1.56 0.01 0
0.75 0.09 to 1.41 0.027
Depression-two days 701 (97.8%) 4.30 5.23 0.93 0.34 to 1.51 0.002 0
0.84 0.26 to 1.42 0.005
Anxiety-one month 645 (95.0%) 7.29 7.77 0.48 -0.26 to 1.23 0.203 0
0.58 -0.15 to 1.31 0.117
Depression-one month 644 (94.8%) 4.42 5.43 1.00 0.36 to 1.66 0.002 0
1.02 0.37 to 1.66 0.002
Upper row shows unadjusted analysis (primary analysis) Lower row shows adjusted analysis (secondary analysis) ρ = Intraclass correlation 
coefficientHealth and Quality of Life Outcomes 2004, 2:39 http://www.hqlo.com/content/2/1/39
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sistent with the findings of a study of exercise testing by
Channer et al [21] that found no evidence of reassurance.
Limitations of this study
The main limitation of this study relates to our inability to
blind participants to the intervention they received and to
fact that they were involved in a trial of CPU care.
Participants may have been influenced by this knowledge
and improvements in psychological symptoms and qual-
ity of life may represent a positive response to receiving a
novel form of care, rather than improvements specifically
related to CPU care.
The use of cluster randomisation has substantial advan-
tages for pragmatic evaluation of changes in organisation,
particularly if economic evaluation is undertaken [22].
However, the fact that randomisation occurs before
recruitment means that there is the potential for selection
bias. We attempted to reduce this risk by applying
rigorous selection criteria and to address any potential
bias by undertaking a secondary, adjusted analysis. Never-
theless it is possible that selection bias may have influ-
enced the results.
Although the measures used have been validated, they
have not been widely used in the emergency setting.
Changes in health status after an episode of chest pain
may be very rapid, hence our need to measure outcomes
only two days after intervention. Yet the HADS measures
anxiety and depression over the previous week, while
some SF-36 questions refer to the previous month. A
recent episode of chest pain is likely to be an important
determinant of reported health, but it may be that, if par-
ticipants interpreted the questionnaires strictly, the initial
questionnaire was recording health status before the inter-
vention. Also, there may be doubts regarding what some
of the outcomes are actually measuring. For example,
some of the questions in the HADS measure symptoms
HADS scores categorised according to severity Figure 1
HADS scores categorised according to severity
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that are useful markers for depression, such as levels of
activity, which may also be changed by other health or
social processes. Thus it may be that the reduced scores
associated with CPU care measured on the depression
scale relate to increased activity in response to the CPU
exercise treadmill test, rather than reduced depression.
Implications for practice and future research
This study suggests that the assessment that patients
receive when they present with acute chest pain can have
an impact upon their subsequent health, even if this
assessment does not, in most cases, provide a definitive
diagnosis. It supports the findings of decision analysis
modelling [7] that the potential health impact of chest
pain assessment lies as much in addressing quality of life
and psychological symptoms as in detecting and treating
cardiac disease. The CPU assessment simply provides a
rigorous and structured evaluation, yet this appears to
have a significant effect upon anxiety (although this is not
maintained), depression and quality of life.
Yet it is not clear how this effect is achieved. It is possible
that early, rigorous testing, particularly the exercise tread-
mill test, has a valuable effect in reassuring the patient that
they are healthy and capable of normal physical function-
ing. Alternatively, it could be that consistent, reliable
advice and attention from specialist chest pain nurses,
rather than a variety of different doctors, is the key ele-
ment. A third possibility, as previously discussed, is that
bias plays an important role.
Future research needs to determine which of these possi-
bilities is the key factor. This is important for the specific
issue of determining whether and how CPU care is effec-
tive, and thus what elements of CPU care are essential,
and for the more general issue of exploring how diagnos-
tic assessment effects subsequent well being.
Conclusions
CPU care for patients attending hospital with acute, undif-
ferentiated chest pain is associated with reduced initial
anxiety, reduced depression over the following month,
and improvements in most dimensions of quality of life.
Further research is required to establish how this effect is
achieved.
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